Vipragen has a state-of-the-art infrastructure and an experienced team of professionals well-versed in various therapeutic areas and multiple target classes in India. Our commitment is to provide top-notch and cost-effective discovery chemistry services, covering the entire spectrum from target validation to clinical candidacy, with comprehensive support in molecular modelling. These services operate on a full-time-equivalent basis, encompassing hit and lead identification, candidate optimization, and further complemented by process and scale-up chemistry. Integration with discovery biology services facilitates lead optimization, aligning efforts towards the identification of clinical candidates.

DMPK (Drug Metabolism and Pharmacokinetics) services are integral in the pre-clinical phase of drug development within Contract Research Organizations (CROs). Vipragen, as a premier Pre-clinical CRO in India, specializes in offering comprehensive DMPK services to pharmaceutical and biotech companies. Their in-vitro studies focus on molecular-level assessments, including metabolism, solubility, and permeability, crucial for evaluating a compound's suitability for further development. In addition, Vipragen conducts in-vivo studies within living organisms, providing insights into the absorption, distribution, metabolism, and excretion (ADME) of drug candidates in a physiological context, playing a pivotal role in safety, efficacy, and pharmacokinetic assessments.

Vipragen's integrated approach to DMPK services facilitates informed decision-making in drug development, ensuring efficient progression through the pipeline while meeting rigorous regulatory standards. With over a thousand PK (Pharmacokinetics) projects, their highly comprehensive services contribute to a thorough understanding of drug behaviour in biological systems. The organization's strong commitment to future research, resource optimization, efficiency, and dedication to reducing variability in studies positions them as a valuable partner in the success of drug development programs for the pharmaceutical and biotech industries.

Discovery Biology is an interconnected process that swiftly progresses through milestones, aiming to expedite the delivery of a new therapeutic. It focuses on the decision-making process to generate a validated lead candidate for potential pharmaceutical drug development. This involves identifying diverse hit and lead series using various scientific approaches tailored to the program's nature.